Doctors Mark Foglietti and Michael Kellis of the Ohio Stem Cell Treatment Center are developing a treatment utilizing autologous [the patient’s own] stem cells to treat Chronic Traumatic Encephalopathy (CTE). CTE is a degenerative disease that effects people who have been subjected to repeated blows to the head – such as NFL players – especially those whom experienced multiple concussions. After Dr. Bennett Omalu discovered CTE in the autopsy of football player Mike Webster, the disease became the focus of intense research and of these clinical trials. NFL Super Bowl Champ Matt Wilhelm is the first NFL player to participate in the clinical trial. The procedure includes extracting mesenchymal stem cells, concentrating them, and reintroducing them into the injured or diseased part of the patient. Once introduced, the pluripotent stem cells are able to differentiate into the same cells as where they are placed. According to Dr. Foglietti, “The bigger goal is to improve and repair his nervous system so that he never gets CTE, which could also eventually help veterans and anyone else who has suffered a concussion or brain injury”.
As treatments emerge, we believe the best stem cells to use will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn how to bank your own valuable stem cells to insure your future health, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.